retatrutide type 2 diabetes phase 2 trial results 2024 Test on a popular unapproved peptide have revealed a concentration double that listed on the label, prompting warnings from health professionals about "enormous" overdose risks. By national health equity reporters Caitlyn Retatrutide Results: 28.3% Weight Loss
Description
The drugs famously turn off what users call food noise or intrusive thoughts of food
Clinically, this is known as telogen effluvium and has been seen in some GLP-1 patients
Muscle is denser than fat, so your body can be meaningfully changing shape while the scale holds steady
Some describe feeling indifferent to foods they once craved, which can be both beneficial for weight management and concerning if it leads to inadequate nutrition
however, utilization of these agents was low despite elevated HbA 1c levels
The drug is different at different doses
